Hedrin Once Liquid Gel
with 15 minute treatment time
Available from your pharmacist
and in-store medicine aisle
FREE Pharmacy Training Material
Best practice guidelines for tackling head lice.
Developed in partnership with the UK’s leading head lice experts and senior representatives from the pharmacy community.
Pripsen for threadworm
Information Leaflet
Download our helpful leaflet for further reference.
Download (635KB)
Product Information Hedrin 4% Lotion and Hedrin 4% Lotion Spray.
Presentation: cutaneous solution containing 4% dimeticone w/w. Indications: for the eradication of head lice infestations Dosage and administration: Adults and children over 6 months: Apply sufficient lotion to cover dry hair from the base to the tip to ensure that no part of the scalp is left uncovered. Work into the hair spreading the liquid evenly from roots to tips. Allow hair to dry naturally. Hedrin should be left on hair for a minimum of 8 hours or overnight. Wash out with normal shampoo, rinsing thoroughly with water. Repeat the treatment after seven days. Contraindications: Hypersensitivity to any of the ingredients. Precautions and Warnings: Discontinue at the first appearance of a skin rash or any other signs of local or general hypersensitivity. For external use only. If accidentally introduced into the eyes, flush with water. Keep hair away from sources of ignition, especially naked flames and burning cigarettes, whilst being treated with Hedrin. Treated hair can readily burn if ignited. Side Effects: Minor adverse events include an itchy or flaky scalp and dripping/irritation around the eyes. Product Licence Holder: Thornton & Ross Ltd, HD7 5QH Legal Category: 50ml: GSL, 150ml and 120ml: P Price: 50ml: (MRRP ex VAT) £4.24 Trade £2.97 150ml: (MRRP ex VAT) £9.86 Trade £6.92, 120ml: (MRRP ex VAT) £10.20 Trade £7.14 Product Licence No: 50ml: PL00240/0137 150ml and 120ml: PL00240/0345 Date of preparation: July 2010
Healthcare Professionals' Information
4% Dimeticone - effectiveness without restrictions
Hedrin is a novel and highly effective method of eradicating head lice which offers considerable benefits to clinicians and their patients. It is now available both as a licensed medicine and a medical device, both employing the full benefits of 4% dimeticone.
Clinical trials have demonstrated 4% dimeticone's superiority to 0.5% malathion¹ and its effectiveness in large scale tests in-vivo².
A recent experiment by Ian Burgess, Director of the Medical Entymology Centre has also demonstrated that Hedrin's mode of action is entirely a physical process³. Hedrin cannot therefore trigger resistance and can be used as often as required with no complex rotation policies.
For further information and a range of training and information resources, please complete our healthcare professionals' form.
A study into head lice management in the UK
Getting Ahead of Head Lice, addresses current thinking on head lice management in the UK to investigate whether best practice and the latest advice is being adopted.
The Hedrin Report: Getting Ahead of Head Lice
Hedrin clinical trials
Efficacy of 4% dimeticone
http://www.bmj.com/cgi/content/full/330/7505/1423
Superiority to 0.5% malathion
http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0001127
Mode of action demonstration
Report and video
4% dimeticone treatment Trial
BMC Research Article